Bhalla A, Pannu A K
Department of Internal Medicine, Postgraduate Institute of Medical Education and Research, 4th Floor, F Block, Nehru Hospital, PGIMER, Chandigarh 160012, India.
Toxicol Res (Camb). 2022 Jan 15;11(1):179-183. doi: 10.1093/toxres/tfab124. eCollection 2022 Feb.
Ayurvedic formulations are widely used and perceived as safer medicine and subjected to be self-prescribed. However, recent reports have demonstrated adulterating these drugs with toxic quantities of heavy metals. To study the magnitude of the problem in Indian-manufactured Ayurvedic medications, we randomly collected common over-the-counter Ayurvedic preparations from the licensed Ayurvedic shops in the local markets of Chandigarh in 2017. The samples were analyzed to identify and quantify eight metal ions, including mercury, arsenic, lead, cadmium, zinc, iron, copper, and chromium, using inductively coupled plasma mass spectrometry in Postgraduate Institute of Medical Education and Research, Chandigarh. The permissible limit set by the Food and Agriculture Organization/World Health Organization (FAO/WHO) for herbal medicines was followed to define the high metal concentrations. Out of 43 Ayurvedic preparations, 42 were analyzed. Heavy metals were detected in all formulations. The median (range) concentrations (in μg/g or mg/kg) of the metals were quantified as follows- mercury, 13.52 (0.00-61 095.99); arsenic, 0.00 (0.00-1038.83); lead, 1.40 (0.00-57.09); zinc, 84.2200 (26.48-22 519.03); iron, 1356.21 (128.24-136 835.25); copper, 17.1450 (0.00-12 756.86) and chromium, 20.9050 (0.00-2717.58). The metal contents above the FAO/WHO-mandated limit for zinc, mercury, arsenic, and lead were detected in 35, 29, 6, and 2 formulations, respectively. All medications contained detectable quantities of zinc and iron. Copper was detected in all except one. Cadmium was not found in any sample. Ayurvedic medications have a high prevalence of heavy metals. An evaluation of the sources of contamination and the necessary drug safety regulations are required.
阿育吠陀配方被广泛使用,且被视为更安全的药物,人们可以自行开方使用。然而,最近有报告显示这些药物中掺有有毒量的重金属。为了研究印度生产的阿育吠陀药物中这一问题的严重程度,我们于2017年从昌迪加尔当地市场有许可证的阿育吠陀商店中随机收集了常见的非处方阿育吠陀制剂。在昌迪加尔医学教育与研究研究生院,使用电感耦合等离子体质谱法对样本进行分析,以识别和量化包括汞、砷、铅、镉、锌、铁、铜和铬在内的8种金属离子。遵循食品及农业组织/世界卫生组织(粮农组织/世卫组织)为草药设定的允许限量来界定高金属浓度。在43种阿育吠陀制剂中,对42种进行了分析。所有制剂中均检测到重金属。这些金属的中位数(范围)浓度(以μg/g或mg/kg计)如下:汞,13.52(0.00 - 61095.99);砷,0.00(0.00 - 1038.83);铅,1.40(0.00 - 57.09);锌,84.2200(26.48 - 22519.03);铁,1356.21(128.24 - 136835.25);铜,17.1450(0.00 - 12756.86);铬,20.9050(0.00 - 2717.58)。分别在35种、29种、6种和2种制剂中检测到锌、汞、砷和铅的金属含量超过了粮农组织/世卫组织规定的限量。所有药物中都含有可检测量的锌和铁。除一种外,所有制剂中均检测到了铜。在任何样本中均未发现镉。阿育吠陀药物中重金属的含量普遍较高。需要对污染来源进行评估并制定必要的药物安全法规。